Where the peptide literature meets regenerative medicine - signalling peptides, self-assembling peptide hydrogels and scaffolds, growth factors, and the stem-cell research they intersect with. Mechanism-level, research use only.
4 articles tagged “Regenerative Research”
Why the horse is a serious soft-tissue-repair model, the real actin/cell-migration mechanisms behind TB-500, the human-to-horse evidence gap, and the racing anti-doping reality most sellers omit.
The real angiogenic and fibroblast-migration mechanisms behind BPC-157’s equine "soft-tissue" claims, why the evidence is overwhelmingly preclinical, the human-to-horse gap, and the medication-control rules recovery marketing skips.
BPC-157 and TB-500 are scheduled for FDA advisory committee discussion on July 23, 2026 (evaluated uses: ulcerative colitis and wound healing). What it means for regenerative peptide research, compounding policy and research-use standards - and why a review is not an approval.
How peptides intersect with stem-cell and regenerative-medicine research - as signalling molecules, as self-assembling hydrogel scaffolds for 3D cell culture, and as growth factors such as IGF-1. What the peer-reviewed literature describes vs the longevity-clinic claims. Research use only.
Research use only. These articles summarise public literature and catalogue facts. They do not diagnose, treat, or prevent any disease, and are not medical advice.